Home / Brands / SCA Pharmaceuticals
SCA Pharmaceuticals Recalls
166 recalls on record · January 21, 2015 to April 3, 2024 · Drugs
Recalls by year
15
17
18
19
20
21
22
23
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls HYDROmorphone HCl 6 mg/30mL in 0.9% Sodium Chloride Injection (0.2 mg/mL), Rx Only, a) 30 mL Plungerless Single Dose Syr
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls Glycopyrrolate 1 mg/5mL (0.2mg/mL), 5 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor,
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls fentaNYL 1500 mcg/30 mL (50 mcg/mL), 30 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor,
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls fentaNYL 100 mcg/50mL Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 50 mL, 50 mL Single Dose Syringe, Rx Only, SCA Phar
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls fentaNYL 100 mcg/50mL Ropivacaine HCl 0.1% in 0.9% Sodium Chloride 50 mL, 50 mL Single Dose Syringe, Rx Only, SCA Pharm
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls Esmolol HCl 100 mg/10 mL (10mg/ mL), 10 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls ePHEDrine Sulfate 50 mg/10mL in 0.9% Sodium Chloride Injection, 10 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals,
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls ePHEDrine Sulfate, 50 mg/5mL in 0.9% Sodium Chloride Injection, 5 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals,
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls Buffered Lidocaine HCl, 1%, 5 mL (10mg/mL) with Sodium Bicarbonate Injection for Local Anesthetic Use, 5 mL Single Dose
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
January 13, 2021DrugsFDA
SCA Pharmaceuticals recalls Atropine Sulfate Injection, 0.8 mg/2 mL (0.4 mg/mL), 2 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow
Hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
December 30, 2020DrugsFDA
SCA Pharmaceuticals, Inc. recalls Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA Pharmaceuticals 8821 Knoed
Hazard: Subpotent drug.
December 23, 2020DrugsFDA
SCA Pharmaceuticals recalls Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205
Hazard: Subpotency: Out-of-specification stability test result for low potency was obtained.
September 2, 2020DrugsFDA
SCA Pharmaceuticals recalls Heparin Sodium 10,000 units in 0.9% Sodium Chloride 1000 mL, Single Dose Container, Rx Only Injection for Intravenous Us
Hazard: Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
September 2, 2020DrugsFDA
SCA Pharmaceuticals recalls Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL, Single Dose Container, Rx Only Injection for Intravenous Use
Hazard: Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
September 2, 2020DrugsFDA
SCA Pharmaceuticals recalls Heparin Sodium 5,000 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use
Hazard: Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
September 2, 2020DrugsFDA
SCA Pharmaceuticals recalls Heparin Sodium 2,500 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use
Hazard: Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
August 19, 2020DrugsFDA
SCA Pharmaceuticals recalls Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx only, SCA Pharmaceuticals 755 Rainbow Rd
Hazard: Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.
June 24, 2020DrugsFDA
SCA Pharmaceuticals recalls Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx Only, SCA Pharmaceuticals 755 Rainbow Rd
Hazard: Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.
December 18, 2019DrugsFDA
SCA Pharmaceuticals, LLC recalls Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09
Hazard: Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).
August 28, 2019DrugsFDA
SCA Pharmaceuticals, LLC recalls Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use (concentration = 10 mg/mL), 6 mL Syringe, Rx Only
Hazard: Lack of Assurance of Sterility.
September 19, 2018DrugsFDA
SCA Pharmaceuticals, Inc. recalls Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmac
Hazard: Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.
July 18, 2018DrugsFDA
SCA Pharmaceuticals recalls Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total
Hazard: Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Phenylephrine HCL 80mg in 0.9% Sodium Chloride 250 mL Bag (320 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Phenylephrine HCL 50 mg in 0.9% Sodium Chloride 250 mL Bag (200 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Phenylephrine HCL 20 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Phenylephrine HCL 40 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Phenylephrine HCL 10 mg in 0.9% Sodium Chloride 250 mL Bag (40 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Norepinephrine Bitartrate 16 mg (64 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Norepinephrine Bitartrate 8 mg (32 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
July 11, 2018DrugsFDA
SCA Pharmaceuticals, LLC recalls Norepinephrine Bitartrate 4 mg (16 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT
Hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.